Jiangsu Zhongbang Pharmaceutical Co. Ltd. Jiangsu Zhongbang Pharmaceutical Co. Ltd. has been founded in 2001. As a high-tech enterprise, Zhongbang focuses on developing and producing pharmaceutical intermediates, APIs and finished products. The registered capital of Zhongbang is $1.26 billion and total...
Products| Zhongbang Pharmaceutical Relying on the advantages of the pyridine industry chain of Red Sun Group, Zhongbang Pharmaceutical has unique starting materials and cost advantages in the field of pazole APIs and intermediates. Zhongbang Pharmaceutical also has its own expertise in the field of sar...
Jiangsu Zhongbang Pharmaceutical Co. Ltd. has been founded in 2001. As a high-tech enterprise, Zhongbang focuses on developing and producing pharmaceutical intermediates, APIs and finished products. The registered capital of Zhongbang is $1.26 billion and total area is 100,000 m2. After a rapid ...
Jiangsu Zhongbang made its debut successfully at the CPhI China 2023 at Shanghai New International Expo Center on June 19-21. The global leader in Esomeprazole series products attended the event with its latest innovations. This year's event saw the return of international attendees for the first...
Profile: Jiangsu Zhongbang Pharmaceutical Co., Ltd. is a producer of APIs, feed additives and intermediates. Our APIs include telmisartan, candesartan cilexetil, letrozole, nicotinamide, lansopraz.. Provide products various. Contact us now to get the l
Jiangsu Zhongbang Pharmaceutical Co., Ltd. is a wholly-owned subsidiary of Red Sun Group. ZhongbanggotthefirstChinaGMPcertificatein2006,andrenewed the qualification in 2015.Thecompanyalsohasthe CEPce.. Provide Telmisartan;Telmisartan Sodium;Azilsartan;V
In recent years, Jiangsu Zhongbang has continued to carry out energy-saving and emission reduction renovations. Through technological renovations of existing equipment, the peak load of electricity consumption and high priced electricity consumption during the day have been reduced, with the goal of redu...
No. Product Name Treatment 1 Esomeprazole Magnesium MUPs 15% Anti-ulcerative 2 Esomeprazole Magnesium MUPs 22.5% Anti-ulcerative 3 Esomeprazole Magnesium Enteric-coated Pellets 8.5% Anti-ulcerative 4 Esomeprazole Magnesium Enteric-coated Pellets 22.5% ...
Jiangsu Zhongbang Attended CPhI China 2019 Jun.21,2019 On June 18-20, 2019, the "19th World Pharmaceutical Raw Materials China Exhibition (CPHI China 2019)" was held in Shanghai as scheduled. After years of hard work, CPHI has become the platform of choice for excellent local enterprises to...
Zhongbang is committed to integrate environment, health, and safety (EHS) into how we run our business and achieve higher level of environmental awareness and care. Certificate of ISO 9001, 14001, 45001: